Article
Use of sequence data generated in the Bayer Tru Gene genotyping assay to recognize and characterize non-subtype-b human immunodeficiency virus type 1 strains.
Journal of clinical microbiology - 1 Oct 2005
Hirigoyen Diane L, Cartwright Charles P
Abstract excerpt
Human immunodeficiency virus type 1 (HIV-1) protease (PR) and reverse transcriptase (RT) gene sequences obtained during antiretroviral resistance testing with a commercial genotyping assay (Tru Gene; Bayer Corp.) were analyzed to assess the utility of these data for detecting and characterizing non-subtype-B HIV-1 strains. A total of 125 viral sequences obtained from patients believed to have acquired their HIV-1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
